Short, Nicholas J.
Muftuoglu, Muharrem
Ong, Faustine
Nasr, Lewis
Macaron, Walid
Montalban-Bravo, Guillermo
Alvarado, Yesid
Basyal, Mahesh
Daver, Naval
Dinardo, Courtney D.
Borthakur, Gautam
Jain, Nitin
Ohanian, Maro
Jabbour, Elias
Issa, Ghayas C.
Qiao, Wei
Huang, Xuelin
Kanagal-Shamanna, Rashmi
Patel, Keyur P.
Bose, Prithviraj
Ravandi, Farhad
Delumpa, Ricardo
Abramova, Regina
Garcia-Manero, Guillermo
Andreeff, Michael
Cortes, Jorge
Kantarjian, Hagop
Funding for this research was provided by:
Takeda Oncology
Article History
Received: 26 May 2023
Accepted: 4 July 2023
First Online: 8 July 2023
Declarations
:
: This clinical trial was conducted at a single academic medical center (The University of Texas MD Anderson Cancer Center). The clinical trial was approved by the Institutional Review Board and was conducted in accordance with the Declaration of Helsinki. All participants signed informed consent.
: N.J.S. and E.J. have received research funding and honoraria from Takeda Oncology. The rest of the authors have no relevant conflicts to disclose.